References
- Hennings JM, Schaaf L, Fulda S. Glucose metabolism and antidepressant medication. Curr Pharm Des. 2012;18(36):5900–5919.
- McIntyre RS, Soczynska JK, Konarski JZ, et al. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf. 2006;5(1):157–168.
- Deuschle M. Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatry. 2013;26(1):60–65.
- Chen Y-C, Lin W-W, Chen Y-J, et al. Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males. Mediators Inflamm. 2010;2010:573594.
- Weber-Hamann B, Gilles M, Schilling C, et al. Improved insulin sensitivity in 51 nondiabetic depressed inpatients remitting during antidepressive treatment with mirtazapine and venlafaxine. J Clin Psychopharmacol. 2008;28(5):581–584.
- Khanam R, Najfi H, Akhtar M, et al. Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice. Hum Exp Toxicol. 2012;31(12):1244–1250.
- Meertens JHJM, Monteban-Kooistra WE, Ligtenberg JJM, et al. Severe hypoglycemia following venlafaxine intoxication: a case report. J Clin Psychopharmacol. 2007;27(4):414–415.
- Francino M-C, Bretaudeau Deguigne M, Badin J, et al. Hypoglycaemia: a little known effect of Venlafaxine overdose. Clin Toxicol (Phila). 2012;50(3):215–217.
- Brvar M, Koželj G, Mašič LP. Hypoglycemia in venlafaxine overdose: a hypothesis of increased glucose uptake. Eur J Clin Pharmacol. 2015;71(2):261–262.
- Ling Y, Khara L, Alvarez G, et al. Persistent hypoglycemia in venlafaxine overdose. Arch Clin Med Case Rep. 2019;03:94–99.
- Schiestel T. Venlafaxine poisoning-induced severe hypoglycemia in a non-diabetic patient: a case report. Asia Pac J Med Tox. 2020;9(3):119–122.
- Kobylianskii J, Wu PE. Venlafaxine-induced hypoglycemia. CMAJ. 2021;193(16):E568.
- Chi T-C, Ho Y-J, Chen W-P, et al. Serotonin enhances beta-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. Life Sci. 2007;80(20):1832–1838.
- Paulmann N, Grohmann M, Voigt J-P, et al. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009;7(10):e1000229.
- Derijks HJ, Meyboom RHB, Heerdink ER, et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol. 2008;64(5):531–538.
- Choi SB, Jang JS, Park S. Tramadol enhances hepatic insulin sensitivity via enhancing insulin signaling Cascade in the cerebral cortex and hypothalamus of 90% pancreatectomized rats. Brain Res Bull. 2005;67(1–2):77–86.
- Cheng JT, Liu IM, Chi TC, et al. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. 2001;50(12):2815–2821.
- Schönberg L, Grobosch T, Lampe D, et al. Toxicological screening in urine: comparison of two automated HPLC screening systems, toxicological identification system (TOX.I.S.) versus REMEDI-HS. J Anal Toxicol. 2007;31(6):321–327.
- Persson HE, Sjöberg GK, Haines JA, et al. Poisoning severity score. Grading of acute poisoning. Clin Toxicol (Phila). 1998;36(3):205–213.
- Conner KR, Wiegand TJ, Gorodetsky R, et al. Poisoning severity associated with a range of medications in suicide attempts by ingestion. Suicide Life Threat Behav. 2019;49(3):635–642.
- Conner KR, Wiegand TJ, Gorodetsky R, et al. Validation of the Poisoning Severity Score (PSS) in suicidal behavior by self-poisoning. Behav Sci Law. 2019;37(3):240–246.
- Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236–241.
- Balijepalli C, Druyts E, Siliman G, et al. Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes. Clin Epidemiol. 2017;9:291–296.
- Basu R, Dalla Man C, Campioni M, et al. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes. 2006;55(7):2001–2014.
- Mortensen EM, Garcia S, Leykum L, et al. Association of hypoglycemia with mortality for subjects hospitalized with pneumonia. Am J Med Sci. 2010;339(3):239–243.
- Mendoza A, Kim YN, Chernoff A. Hypoglycemia in hospitalized adult patients without diabetes. Endocr Pract. 2005;11(2):91–96.
- Vihonen H, Kuisma M, Nurmi J. Hypoglycaemia without diabetes encountered by emergency medical services: a retrospective cohort study. Scand J Trauma Resusc Emerg Med. 2018;26(1):12.
- Finfer S, Liu B, Chittock DR, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367(12):1108–1118.
- Murad MH, Coto-Yglesias F, Wang AT, et al. Clinical review: drug-induced hypoglycemia: a systematic review. J Clin Endocrinol Metab. 2009;94(3):741–745.
- Bansal N, Weinstock RS. Endotext: non-diabetic hypoglycemia. South Dartmouth (MA): MDText.com, Inc.; 2000.
- Soroosh D, Zakariaei Z, Azadeh H, et al. Occurrence of hypoglycemia in patients with benzodiazepines poisoning: a cross-sectional study. Ann Med Surg (Lond). 2021;69:102772.
- Ben Salem C, Fathallah N, Hmouda H, et al. Drug-induced hypoglycaemia: an update. Drug Saf. 2011;34(1):21–45.
- De Canecaude C, Rousseau V, Sommet A, et al. Tramadol-induced hypoglycemia: a pharmacovigilance study. Fundam Clin Pharmacol. 2021;35(5):933–936.
- Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
- Decker L, Hanon O, Boureau A-S, et al. Association between hypoglycemia and the burden of comorbidities in hospitalized vulnerable older diabetic patients: a cross-sectional, population-based study. Diabetes Ther. 2017;8(6):1405–1413.
- Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124(11):1028–1035.
- Özdemir S. A case report of rare adverse events associated with venlafaxine administration: hypoglycemia and lactic acidosis. Korean J Fam Med. 2022;43(1):83–85.
- Gagnon J, Lussier MT, MacGibbon B, et al. The impact of antidepressant therapy on glycemic control in Canadian primary care patients with diabetes mellitus. Front Nutr. 2018;5:47.
- Sabzghabaee AM, Eizadi-Mood N, Gheshlaghi F, et al. Is there a relationship between admission blood glucose level following acute poisoning and clinical outcome? Arch Med Sci. 2011;7(1):81–86.
- Swaen G, van Amelsvoort L. A weight of evidence approach to causal inference. J Clin Epidemiol. 2009;62(3):270–277.
- Golightly LK, Simendinger BA, Barber GR, et al. Hypoglycemic effects of tramadol analgesia in hospitalized patients: a case-control study. J Diabetes Metab Disord. 2017;16:30.
- Fournier J-P, Azoulay L, Yin H, et al. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med. 2015;175(2):186–193.
- Makunts T, U A, Atayee RS, et al. Retrospective analysis reveals significant association of hypoglycemia with tramadol and methadone in contrast to other opioids. Sci Rep. 2019;9(1):12490.
- Hernán MA. Methods of public health research — strengthening causal inference from observational data. N Engl J Med. 2021;385(15):1345–1348.
- Bogowicz P, Curtis HJ, Walker AJ, et al. Trends and variation in antidepressant prescribing in english primary care: a retrospective longitudinal study. BJGP Open. 2021;5(4):BJGPO.2021.0020.
- Sultana J, Italiano D, Spina E, et al. Changes in the prescribing pattern of antidepressant drugs in elderly patients: an Italian, nationwide, population-based study. Eur J Clin Pharmacol. 2014;70(4):469–478.
- Luo Y, Kataoka Y, Ostinelli EG, et al. National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis. Front Psychiatry. 2020;11:35.
- McDowell R, Bennett K, Moriarty F, et al. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011–2016): an interrupted time-series study. BMJ Open. 2018;8(4):e019315.
- Wellington K, Perry CM. Venlafaxine extended-release: a review of its use in the management of major depression. CNS Drugs. 2001;15(8):643–669.